UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells

Journal of hematology and oncology, 2024-08, Vol.17 (1), p.67-18

2024

Volltextzugriff (PDF)

Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme

Cells (Basel, Switzerland), 2024-06, Vol.13 (13), p.1075

2024

Volltextzugriff (PDF)

Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms

Journal of clinical oncology, 2024-08

2024

Volltextzugriff (PDF)

A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm

Molecular oncology, 2024-06

2024

Volltextzugriff (PDF)

The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia

Leukemia & lymphoma, 2024-08, p.1

2024

Volltextzugriff (PDF)

First-in-human autologous CAR-T for metastatic breast cancers to target growth factor receptor MUC1

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS2683-TPS2683

2024

Volltextzugriff (PDF)

A Year of Monthly Reflections

Transplantation and cellular therapy, 2024-07, Vol.30 (7), p.633-636

2024

Volltextzugriff (PDF)

A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

Molecular therapy, 2024-07

2024

Volltextzugriff (PDF)

PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.6534-6534

2024

Volltextzugriff (PDF)

Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings

Bone marrow transplantation (Basingstoke), 2024-08

2024

Volltextzugriff (PDF)

Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation

Leukemia research, 2024-10, Vol.145, p.107565, Article 107565

2024

Volltextzugriff (PDF)

Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

Clinical lymphoma, myeloma and leukemia, 2024-06

2024

Volltextzugriff (PDF)

Abstract 6676: Microbiome modification impacts PSCA directed chimeric antigen receptor (CAR) T cell therapy for prostate cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6676-6676

2024

Volltextzugriff (PDF)

Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection

Open forum infectious diseases, 2024-08, Vol.11 (8), p.ofae409

2024

Volltextzugriff (PDF)

Abstract P20: Anti-CD123 CAR NK cells and cam161533 Trispecific Killer Engager have synergistic activity against Acute Myeloid Leukemia

Blood cancer discovery, 2024-03, Vol.5 (2_Supplement), p.P20-P20

2024

Volltextzugriff (PDF)

Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies

Blood advances, 2024-08, Vol.8 (15), p.4066-4076

2024

Volltextzugriff (PDF)

Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy

Transplantation and cellular therapy, 2024-09, Vol.30 (9), p.927.e1-927.e9

2024

Volltextzugriff (PDF)

Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy

Transplantation and cellular therapy, 2024-08, Vol.30 (8), p.788.e1-788.e9

2024

Volltextzugriff (PDF)

Abstract CT096: Phase I first-in-human MUC1 targeted autologous CAR T cells for the treatment of metastatic breast cancers

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT096-CT096

2024

Volltextzugriff (PDF)

Tocilizumab for Cytokine Release Syndrome Management after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis

Transplantation and cellular therapy, 2023-05, Vol.29 (8), p.515.e1-515.e7

2023

Volltextzugriff (PDF)

A Pragmatic Approach to Introducing Translational Geroscience Into the Clinic: A Paradigm Based on the Incremental Progression of Aging-Related Clinical Research

The journals of gerontology. Series A, Biological sciences and medical sciences, 2024-09, Vol.79 (9)

2024

Volltextzugriff (PDF)

Role of Walking Energetics and Perceived Fatigability Differs by Gait Speed: The Study of Muscle, Mobility and Aging (SOMMA)

The journals of gerontology. Series A, Biological sciences and medical sciences, 2024-09, Vol.79 (9)

2024

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells

Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme

Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide

Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms

A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm

The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia

First-in-human autologous CAR-T for metastatic breast cancers to target growth factor receptor MUC1

A Year of Monthly Reflections

A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease

Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation

Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

Abstract 6676: Microbiome modification impacts PSCA directed chimeric antigen receptor (CAR) T cell therapy for prostate cancer

Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection

Abstract P20: Anti-CD123 CAR NK cells and cam161533 Trispecific Killer Engager have synergistic activity against Acute Myeloid Leukemia

Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies

Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy

Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation

Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy

Abstract CT096: Phase I first-in-human MUC1 targeted autologous CAR T cells for the treatment of metastatic breast cancers

Tocilizumab for Cytokine Release Syndrome Management after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis

A Pragmatic Approach to Introducing Translational Geroscience Into the Clinic: A Paradigm Based on the Incremental Progression of Aging-Related Clinical Research

Role of Walking Energetics and Perceived Fatigability Differs by Gait Speed: The Study of Muscle, Mobility and Aging (SOMMA)

Aktive Filter

Suchergebnisse filtern